ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,576Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 251

$460K Total Retail Price of All Prescriptions

Rank: 25 out of 251

340 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,922 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
SIMVASTATIN 506 396 1 1
LISINOPRIL 505 421 2 2
METOPROLOL TARTRATE 320 253 3 7
FUROSEMIDE 305 278 4 6
OMEPRAZOLE 296 256 5 5
LEVOTHYROXINE SODIUM 261 198 6 3
HYDROCHLOROTHIAZIDE 225 207 7 9
ATENOLOL 207 168 8 12
METOPROLOL SUCCINATE 198 181 9 13
WARFARIN SODIUM 177 152 10 11
AMLODIPINE BESYLATE 161 149 11 4
METFORMIN HCL ER 115 78 12 65
TAMSULOSIN HCL 109 89 13 32
ATORVASTATIN CALCIUM 108 106 14 8
LOVASTATIN 92 89 15 31
CITALOPRAM HBR 87 71 16 15
ALLOPURINOL 86 66 17 34
NEXIUM 85 60 18 28
PANTOPRAZOLE SODIUM 85 71 18 20
VENTOLIN HFA 85 50 18 76
SPIRIVA 82 53 21 37
LOSARTAN POTASSIUM 82 76 21 17
ADVAIR DISKUS 79 43 23 25
TRAMADOL HCL 78 65 24 24
HYDROCODONE-ACETAMINOPHEN 77 63 S3 25 18
GABAPENTIN 77 56 25 16
ESCITALOPRAM OXALATE 75 75 27 43
LIDODERM 72 66 28 69
POTASSIUM CHLORIDE 72 56 28 33
DILTIAZEM 24HR CD 71 71 30 93
SERTRALINE HCL 70 40 31 22
TRAZODONE HCL 69 59 32 26
MIRTAZAPINE 69 69 32 36
CYMBALTA 66 41 34 47
DONEPEZIL HCL 66 66 34 29
METFORMIN HCL 65 49 36 10
DIOVAN 65 65 36 23
VENLAFAXINE HCL ER 65 40 36 58
PRAVASTATIN SODIUM 59 46 39 14
NAMENDA 57 57 40 44
RANITIDINE HCL 55 26 41 35
QUETIAPINE FUMARATE 51 32 42 50
PROAIR HFA 50 32 43 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.